Actavis Asks Full Fed. Circ. To Nix 'Amorphous' Panel Ruling
Actavis Laboratories FL Inc. asked the full Federal Circuit on Wednesday to revisit an August panel decision in a case over weight loss pill patents, citing a partial dissent by one...To view the full article, register now.
Already a subscriber? Click here to view full article